Publikationen, an denen er mitarbeitet L. Gil Martínez (1)

2024

  1. Durable benefit and slowdown in tumor growth dynamics with erdafitinib in a FGFR3-TACC3 fusion-positive IDH-wild type glioblastoma

    Neuro-Oncology Advances